Halozyme Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by TD Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2012-12-31 | $105k | 16k | 6.73 |
2012-09-30 | $118k | 16k | 7.56 |
2012-06-30 | $138k | 16k | 8.85 |
2012-03-31 | $172k | 14k | 12.74 |
2011-12-31 | $146k | 15k | 9.54 |
2011-09-30 | $94k | 15k | 6.14 |
2011-06-30 | $106k | 15k | 6.93 |
2011-03-31 | $103k | 15k | 6.73 |
2010-12-31 | $121k | 15k | 7.91 |